CME and CFTC Clash Over On-Chain Perpetual Futures

The U.S. Commodity Futures Trading Commission's decision to allow blockchain-based perpetual futures has sparked a heated battle with the CME Group, the country's largest derivatives exchange operator. The CME has filed a lawsuit against the CFTC, arguing that the regulator is misapplying the law by permitting products that don't have an expiration date, which is a key characteristic of traditional futures contracts. The CME claims that these perpetual futures, also known as perps, are harmful to its own long-dated futures products and that the CFTC's sudden embrace of them did not consider the potential consequences. The dispute centers on the CFTC's approval of perps listings by Kalshi and Coinbase, which the CME says were rubber-stamped without proper review. The CME's lawsuit argues that perps are essentially swaps, which are subject to different regulatory and tax regimes than futures. The CFTC's decision to allow perps has been seen as a significant development in the rapidly growing market for decentralized finance, with non-U.S. perps volume reportedly reaching $60 trillion in the past year. The outcome of the lawsuit could have far-reaching implications for the U.S. approach to regulating this market. The CME's chairman, Terry Duffy, has been vocal in his criticism of the CFTC's decision, saying that the regulator is not prepared to enforce its emerging perps policy properly. The CFTC's chairman, Mike Selig, has defended the agency's approach, saying that it is trying to allow for innovation and competition in the market. The dispute has sparked a wider debate about the role of regulators in shaping the development of new financial products and the balance between innovation and investor protection.